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Background. Effective influenza surveillance requires new methods capable of rapid and inexpensive genomic analysis of
evolving viral species for pandemic preparedness, to understand the evolution of circulating viral species, and for vaccine
strain selection. We have developed one such approach based on previously described broad-range reverse transcription PCR/
electrospray ionization mass spectrometry (RT-PCR/ESI-MS) technology. Methods and Principal Findings. Analysis of base
compositions of RT-PCR amplicons from influenza core gene segments (PB1, PB2, PA, M, NS, NP) are used to provide sub-
species identification and infer influenza virus H and N subtypes. Using this approach, we detected and correctly identified 92
mammalian and avian influenza isolates, representing 30 different H and N types, including 29 avian H5N1 isolates. Further,
direct analysis of 656 human clinical respiratory specimens collected over a seven-year period (1999–2006) showed correct
identification of the viral species and subtypes with .97% sensitivity and specificity. Base composition derived clusters
inferred from this analysis showed 100% concordance to previously established clades. Ongoing surveillance of samples from
the recent influenza virus seasons (2005–2006) showed evidence for emergence and establishment of new genotypes of
circulating H3N2 strains worldwide. Mixed viral quasispecies were found in approximately 1% of these recent samples
providing a view into viral evolution. Conclusion/Significance. Thus, rapid RT-PCR/ESI-MS analysis can be used to
simultaneously identify all species of influenza viruses with clade-level resolution, identify mixed viral populations and
monitor global spread and emergence of novel viral genotypes. This high-throughput method promises to become an integral
component of influenza surveillance.
Citation: Sampath R, Russell KL, Massire C, Eshoo MW, Harpin V, et al (2007) Global Surveillance of Emerging Influenza Virus Genotypes by Mass
Spectrometry. PLoS ONE 2(5): e489. doi:10.1371/journal.pone.0000489
INTRODUCTION
Influenza viruses cause serious global economic and public health
burdens. Annual influenza epidemics resulted in more than 30,000
deaths a year in the United States during 1990–1999[1,2]. Periodic
pandemics result in significantly higher death tolls. Emergence of
new influenza A virus strains can be caused by ‘‘antigenic shift,’’
resulting from reassortment of gene segments, including H and/or
N types[3,4], ‘‘antigenic drift’’ resulting from the continuing
accumulation of mutations in the H and N genes[5], or
a pathogenic virus jumping species and acquiring the ability to
infect and be transmitted among humans, as in the 1918
pandemic[6]. The recent outbreak of highly pathogenic H5N1
avian influenza virus (HPAI), which originated in Southeast Asia
and has since spread globally, has resulted in 166 deaths (272
confirmed human cases) as of February 6, 2007 (http://www.who.
int/en/). The global emergence of this virus has brought renewed
urgency to the effort to track the spread and the evolution of
influenza viruses.
Currently, rapid methods for influenza virus diagnosis rely on
antigen-specific antibody probes[7], or real-time reverse transcrip-
tion PCR (RT-PCR) analysis of the matrix (M) gene for
identification of the viral species[8,9] followed by H and N sub-
type specific RT-PCR assays for determination of the viral sub-
types[10,11]. Since there are many H and N subtypes with
significant intra- and inter-subtype sequence variations, these
methods do not identify all H and N subtypes, nor are they likely
to identify reassortants or newly emerging genetic variants.
Further, none of the current surveillance methods provide
information relevant to tracking antigenically novel strains that
emerge each year or distinguish amongst multiple lineages of
influenza viruses that can co-circulate and persist in a popula-
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genetic analyses are necessary to fully understand the multiple
lineages of viruses, recognize newly emergent influenza variants,
and monitor global spread of these viruses[12,13]. For instance,
analysis of human influenza virus H3N2 sequences from 1999–
2004 revealed that at least three major clades of influenza viruses
were in circulation after the 2002–2003 influenza season[12].
The differences were due to multiple reassortment events though
all shared a common H-gene lineage. Several similar whole-
genome studies with avian influenza viruses have revealed the
presence of multiple, region-specific sub-lineages of the HPAI
H5N1 virus in Southeast Asia that are spreading to Europe and
Africa[14–18].
We have developed a method based on broad-range RT-PCR
followed by electrospray ionization mass spectrometry (RT-PCR/
ESI-MS) for rapid and accurate detection of influenza virus, sub-
species characterization, and early identification of genetic
changes in circulating viruses. This method has previously been
applied to detection of other pathogens in human clinical
samples[19,20,21,22], but it has unique capabilities and advan-
tages for influenza surveillance. Here, we show how a high-
throughput assay incorporating eight parallel RT-PCR reactions
followed by ESI-MS analysis can be used to simultaneously survey
for all species of influenza viruses, provide clade-level resolution,
identify mixed viral populations in the same sample, detect
reassortants, and facilitate monitoring of viral evolution, all
integral components of broad influenza surveillance.
RESULTS
Detection of influenza virus by RT-PCR/ESI-MS
To measure the breadth of coverage and resolution offered by the
panel of primers described in Methods (details in Table S1), we
tested 92 well-characterized influenza virus isolates collected from
human, avian, and animal species. Despite the extensive genetic
diversity of this sample set, the broad-range primers generated
amplicons from all isolates, and base composition signatures
distinguished the isolates (Figure 1). Most isolates showed base
compositions consistent with expected signatures for the corre-
sponding H/N sub-types based on bioinformatic analysis of
existing sequence data. Two of the isolates, however, showed
previously unknown base compositions at several primer loci
suggesting these might be novel influenza virus types; these are
noted as ‘‘Unknown’’ in Figure 1.
Base composition signatures provide a multidimensional finger-
print of the genomes of the various viruses, which can be used to
determine clusters of related species/sub-types. One such
representation (Figure 2) shows base composition data derived
from the PA, PB1, and NP gene segments analyzed on individual
axes. Importantly, only three of the six influenza A primer pairs
from Figure 1 are visualized on this three-dimensional plot. There
was strong agreement between the bioinformatic analysis of
sequence data from GenBank and experimental measurements of
base composition signatures from Figure 1. Human H3N2 and
H1N1 viruses clustered independently from each other and from
the avian/human H5N1 and H1N1 viruses.
RT-PCR/ESI-MS detection of influenza virus in
human clinical specimens
To assess the utility of the RT-PCR/ESI-MS assay for surveillance
of influenza virus in human populations, we analyzed 656 blinded
clinical samples collected over a seven-year period (1999–2006).
The results were compared with conventional analysis of the same
samples by virus culture/serology and real-time RT-PCR
methods. Two hundred forty-three samples were influenza positive
both by RT-PCR/ESI-MS and conventional assays. Ten samples
were positive only by RT-PCR/ESI-MS while eight samples were
positive only by culture/real-time RT-PCR, corresponding to
approximately 97% sensitivity and 98% specificity. Of the
influenza-positive samples, RT-PCR/ESI-MS analysis identified
186 as influenza A virus and 67 as influenza B virus, in complete
agreement with conventional typing methods.
Base composition analysis of multiple RNA segments enables
further categorization of isolates into previously established clades
determined by sequencing (details shown in Table S2). Of the 186
influenza A samples, we determined that 149 of were H3N2
subtype and 34 were H1N1. The subtype of three samples could
not be distinguished between H3N2 and H1N2 because these
viruses probably arose from a recent reassortment of the H gene
from an H1N1 virus with gene segments from an H3N2 virus[12].
Importantly, our predictions agreed completely with serology and
direct RT-PCR analysis of the H and N segments from these
samples. Nonetheless, although base composition analysis of the
PB1, NP, M1, PA, and NS gene segments can be highly predictive
of the H and N types, direct analysis of the H and N segments is
necessary for unambiguous subtyping due to the potential for viral
reassortment.
In addition to identification and species typing, RT-PCR/ESI-
MS provided a quantitative estimate of the number of viral
genome copies in the original patient sample. This was achieved
by including a fixed amount (300 copies/well) of an internal RNA
calibration standard in each PCR reaction[19–22]. The genome
copy numbers in the influenza samples ranged from low (,100
genome copies per well) to intermediate (100–2,500 copies/well)
to high (.3,000 copies per well). Based on the samples within the
linear range of the calibration standard, we estimated an average
genome load of 750 copies/PCR reaction, representing an average
viral load of ,1.5610
4 genomes from material extracted from the
original swab or 200 mL of a nasal aspirate. Six of the samples
required serial dilutions to obtain viral concentrations in the
quantifiable spectrum and ranged from 1.5610
6 to 8.0610
7
genomes/swab. Thus, for influenza-positive patients with re-
spiratory symptoms, we observed a range of five orders of
magnitude in viral RNA shedding.
RT-PCR/ESI-MS tracking of influenza virus evolution
To demonstrate the capabilities of RT-PCR/ESI-MS to track the
evolution of circulating influenza viruses, we created a tree
representation of the H3N2 influenza virus sequences from
Genbank (Figure 3, black) as described in Methods. The 104
experimentally determined H3N2 base compositions were
mapped onto this tree (Figure 3, blue). Analysis revealed
a distribution very similar to the sequence-derived clades of
Holmes et al.[12]. The branch terminating in clade A represents
the dominant branch between years 1999–2004, with a clade B
branch that co-circulates in the same time period. Strikingly,
however, clade-A isolates were not detected after this time and
only clade-B viruses were found circulating world-wide post the
2003–2004 season, as determined by both viral sequence entries in
GenBank and our experimental analysis of patient samples.
The tree was further expanded by the addition of 174 influenza
A H3N2 base compositions, resulting in 29 distinct base
composition types (BC types), from samples collected in North
America during the 2005–2006 season (Figure 3, red). The most
abundant BC type observed in 2005–2006 (AADFAA, 97
instances) was also one of the more abundant BC types from the
previous winter flu season in the southern hemisphere (e.g., A/
Canterbury/125/2005; Figure 3, 2005 South), suggesting that this
Influenza Detection by ESI-MS
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founder of the 2005–2006 BC types in the northern hemisphere.
Most of the other BC types observed in the 2005–2006 season
were within one or two mutations of this major BC type,
suggesting that these might have been derived from AADFAA
through mutations during the 2005–2006 season. A second BC-
type (AABFAA), which differs from AADFAA by a single mutation
in the M1 locus, was also observed in the 2005 South and 2005–
2006 North seasons and was potentially the founder of several
additional BC types observed in 2005–2006. The locations of the
mutations within each target locus responsible for base composi-
tion changes observed in the 2005–2006 northern isolates were
verified by direct sequencing of the PCR products (results shown
in Table S3) and confirmed the findings described above. A visual
display of the most likely relationships among the isolates is shown
in Figure 4. Collectively, these results demonstrate the richness of
the genetic information provided by direct RT-PCR/ESI-MS
analysis of human clinical materials.
Figure 1. Detection and characterization of important human and avian influenza virus subtypes. Base composition signatures are shown in A, G,
C, T order. Identical base compositions within a column are the same color. Base compositions represented only once are shown in white. Base
compositions from human H1N1, human H3N2 and avian/human H5N1 isolates (in green, blue and red boxes, respectively) are included in Figure 2.
doi:10.1371/journal.pone.0000489.g001
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and emerging genetic variants
Infections with more than one influenza virus type can be
identified with high sensitivity by RT-PCR/ESI-MS. Figures 5A
and 5B show spectra from two clinical samples, each containing
a mixture of two different viral BC types observed in samples
collected during the 2005–2006 season. Figures 5A and B show the
spectra from samples containing a mixture of the ‘‘parent’’ BC-
type AADFAA and single-nucleotide variations AAHFAA and
AADFBB, respectively, providing a snapshot of enduring ‘‘fit’’
quasispecies contributors and of potential viral evolution in action.
The dynamic range for mixed RT-PCR/ESI-MS detections has
previously been determined to be approximately 100:1[20], which
allows for detection of viral variants with as low as 1% abundance
in a mixed population. Figures 5C and 5D show results obtained
with a clinical sample containing a mixture of viruses at the limit of
detection for mixed populations. To demonstrate that these peaks
truly represented mixed viral populations, the PCR amplicons
were cloned and 450 independent colonies were sequenced. Nine
(2%) of these 450 clones had the predicted mutations, correlating
well with the measured amplitude of the low-abundance peaks.
A total of 293 non-overlapping nucleotides, excluding the
primer regions, were analyzed using the genetic loci targeted by
the influenza A primers. This corresponds to 2.15% of the
influenza A virus genome. Out of 174 human samples analyzed
from the 2005–2006 season, only two showed evidence for mixed
viral populations at one of the six loci, corresponding to 1.1% of
the samples. Thus, assuming the same mutation rate for the
broader viral genome as for the region analyzed by PCR/ESI-MS,
about 50% of the human H3N2 virus samples would have a mixed
population of viruses.
DISCUSSION
Choosing amongst the various molecular methods available for
pandemic influenza surveillance requires consideration of both
practical issues (e.g., broad availability, convenience, cost, and
throughput) and scientific issues relevant to public health (e.g.,
sensitivity, breath of coverage, and the depth and value of the
information provided). At one end of the spectrum, a conventional
RT-PCR test with specific primers and probes provides a highly-
specific, sensitive, rapid, convenient, quantitative, relatively in-
expensive, and high-throughput format that can provide valuable
surveillance information. However, these tests are not optimal for
surveillance when the exact nature of the pandemic virus is not
known. Moreover, without supplemental nucleic acid sequencing,
conventional RT-PCR-based tests are not capable of signaling the
appearance of new genetic variants, except by potentially
demonstrating a loss of sensitivity. Further, a single RT-PCR test
can achieve only a single presence/absence analysis limited to the
specific target for which it was designed. Discrimination of all
known variants of influenza at the level of resolution described
here would require hundreds of independent RT-PCR reactions.
At the other end of the spectrum, virus isolation using culture
methods followed by complete genome sequencing does not
require prior knowledge of the virus’ sequence and provides clade-
level resolution and highly detailed information regarding virus
evolution. Unfortunately, this method is slow, labor intensive,
expensive, and low throughput, rendering it ineffective in public
health arenas requiring rapid response.
In this work we describe a novel method that employs some of
the best properties of each of the discussed techniques, and also
supplies additional valuable information not provided by those
techniques. For example, our method may identify mixed
Figure 2. Spatial clustering of influenza virus subtypes. Each axis represents base composition bins (A, G, C, T) from a single primer pair. Solid
symbols represent experimental measurements from this study, while open symbols are calculated base compositions determined from published
sequences. Human isolates are shown as cubes and avian isolates as spheres. H1N1 isolates are shown in green, H3N2 in blue, and H5N1 in red.
Arrows indicate avian influenza viruses isolated from humans.
doi:10.1371/journal.pone.0000489.g002
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viruses. Unique base composition types are
reported using a six-letter code (see text) and are
chronologically sorted bottom to top (color boxes,
seasons 1997 to 2006). From year 2000 onwards,
seasons were labeled ‘‘North’’ and ‘‘South’’ to
reflect the northern or southern hemispheric
origin of the samples. Thick vertical bars represent
the persistence of main types between consecu-
tive seasons. Within each season, the number of
isolates is reported between parentheses for types
encountered more than once. Thin horizontal lines
represent the spawning of new types through the
accumulation of single mutations (left to right).
Black font: types determined through sequence
analysis; blue font: experimentally determined
base composition types; red font: experimentally
determined base composition types for season
2005–06. Ten rare sequence types (,1.5%) were
not uniquely discernable by the base composition
analysis of the eight amplicons used in this
analysis, as more than one subtype produced the
same BC-type. These BC-types are indicated by
asterisks.
doi:10.1371/journal.pone.0000489.g003
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illustrated (i.e., development of ‘‘drift’’ strains) or co-infections with
circulating strains (i.e., potential for development of ‘‘shift’’
strains). Recent advances in ESI-MS using bench-top mass
spectrometers have enabled analysis of PCR amplicons with
sufficient mass accuracy that the nucleotide base composition (the A,
G, C, and T count) of the PCR amplicon can be unambiguously
determined[23]. The approach outlined here provides two impor-
tant advantages for surveillance. First, broad-range primers targeted
to highly-conserved sites within the influenza virus family that flank
highly variable, information-rich regions can be used to amplify
sequences from highly diverse viruses in the same assay. The
measured base compositions allow identification of the viral species
with a high degree of resolution. For this approach, we selected
primer pairs targeting the core gene segments (PB1, PB2, PA, M,
NS, and NP) that have conserved regions spanning all known
influenza viruses and used the resultant base compositions to infer
the influenza virus H/N types. In silico analysis of influenza virus
sequences from the GenBank database showed that this approach
would detectall knowninfluenzaviruses anddistinguish.90% of all
speciesandtypes.Thisovercomesthelimitationsofdirectlytargeting
the H and N segments, which requires specific primer pairs for each
known H/N type. Further, since the H/N segments evolve rapidly,
newly emerging strains might not be readily detected by the
traditional approach.
Second, mixed viral populations in the same sample that differ
only by a single mutation and is present in as low as 1–2% of the
virus population can be identified, providing early insights into viral
evolution as an integral component of surveillance. This informa-
tion-rich result is provided with the same throughput and consum-
able costs as conventional, sequence-specific RT-PCR assays.
The results from 174 influenza A H3N2 samples from the
2005–2006 season in the northern hemisphere were particularly
interesting because they revealed viral evolution during a single
season. The viruses detected appeared to have been seeded from
two of the more abundant BC types circulating during the
previous season in the southern hemisphere. The majority (97) of
the samples had identical BC types and probably arose from
a single founder from the previous season in the southern
hemisphere. Most of the remaining samples differed from this
founder BC type by one or two additional point mutations within
the target regions described here. Surprisingly, when mutations
occurred, they became fixed rapidly in the viral population, since
only two of the 174 samples from the 2005–2006 season showed
evidence of mixed populations. Sequencing revealed that both
mutations were silent transitions in third codon positions.
In summary, the RT-PCR/ESI-MS method has the capacity to
provide rapid diagnosis of human influenza in individual patients
with respiratory symptoms, as well as public health surveillance of
emerging, potentially pandemic strains, including novel reassor-
tants. The use of RT-PCR/ESI-MS for human as well as avian/
animal surveillance offers the potential for new insights into viral
evolution on a scale and at a cost previously not possible. Bench-
top mass spectrometers are capable of analyzing complex PCR
Figure 4. Relationship of founder isolate AADFAA and closest descendents in the 2005–2006 season. The areas of the circles are scaled to the
number of human samples that contained the BC-types. Each concentric ring represents a single, double and triple mutations removed from the
founder isolate, color coded for the gene containing the mutation. The order of the letters in the BC-type correspond to the six primer pairs used in
this study, targeting PB1, NP, PA, M1, NS1 and NS2, respectively.
doi:10.1371/journal.pone.0000489.g004
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making the RT-PCR/ESI-MS technology practical for large-scale
analysis of clinical specimens or for animal surveillance. Further,
as we have demonstrated with influenza viruses, this method
provides sensitive detection directly from patient specimens with
specificity approximating sequence-level resolution. The ability to
quantitate virus shedding, detect low-abundance, mixed infections,
and identify new genetic variants without prior knowledge of viral
sequence also make this technology ideally suited for monitoring
the emergence of drug-resistance mutations during therapy or for
identifying newly emerging antigenic variants.
MATERIALS AND METHODS
Viral samples
Eighteen human influenza virus A (H1N1, H3N2) and six human
influenza virus B isolates were obtained as tissue culture fluids
from the Naval Health Research Center (NHRC, San Diego, CA).
NHRC also supplied 336 human respiratory specimens (240
throat swabs, 26 nasal swabs, and 70 nasal wash specimens)
collected and archived from various U.S. military bases around the
country from 1999 through 2005. The New York State De-
partment of Health, Wadsworth Center (Albany, NY) supplied
100 respiratory specimens collected between 1999–2005 (88
nasopharyngeal aspirates; 12 assorted nasal aspirates, BAL,
tracheal aspirates, and throat swabs). Johns Hopkins University
(JHU, Baltimore, MD) provided 229 nasal aspirates collected
during 2003–2005. The Texas Department of State Health
Services provided a total of 574 assorted throat, sputum, and
nasopharyngeal aspirate specimens collected from 2005 to 2006.
The 63 avian isolates from 16 different avian species were
obtained from the United States (The University of Georgia
collection), Egypt, and Asia/Middle East (Naval Medical Research
Unit #3 (NAMRU-3), Cairo, Egypt). NAMRU-3 also provided all
of the HPAI (avian H5N1) isolates collected from 2006 outbreaks
in Egypt, Iraq, and Central Asia. Equine (VR-297) and swine
isolates (VR-333) were obtained from the American Type Culture
Collection (ATCC). Additional swine isolates were provided by
Dr. Gregory Gray from the University of Iowa. All samples were
collected under appropriate human or animal use protocols, or
from granted exempt use of anonymous clinical specimens, from
the respective organizations.
Figure 5. Detection of mixed viral populations. Panels A, B, and C are representations of mass spectral data. The heat maps in the top sections are
a charge state representation of the data; the spectral plots in the lower sections were created by filtering the charge state responses to create signal
representations vs. mass. The main peaks on the spectral plots are the primary amplicons and appear as hot spots in the charge state representations;
the secondary amplicons appear as ‘‘cloudy’’ regions to the right and left for the forward and reverse strands, respectively. Panels A and B contain
two species in relatively large ratios (20–50% mixtures) and involve the season 2005–2006 parent BC-type (AADFAA) and a type with a single
mutation (panel A, within the M1 amplicon, BC-type AAHFAA; panel B, within the overlapping NS1 and NS2 amplicons, BC-type AADFBB). Panel C
shows detection of a low abundance type (2–5%). Panel D shows a close-up view of the mass spectrum from Panel C. In this view, the shoulder of the
peak is fit with a single mass model (blue dotted line) and a two mass model (dashed red line).
doi:10.1371/journal.pone.0000489.g005
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Viral stock samples consisting of cultured virus or stocks obtained
from ATCC were prepared for analysis using the Qiagen QiaAmp
Virus kit (Valencia, CA). Both manual (mini spin) kits and
BioRobot kits were used. Robotic-based isolations were done on
both the Qiagen MDx and Qiagen BioRobot 8000 platforms.
Clinical swab samples were stored in Viral Transport Media
(VTM). VTM solution (1 ml) was passed over a 0.2 micron filter,
which was then subjected to bead beating in a small amount of
lysis buffer. The resulting viral lysate was then used following the
same protocol as above.
Primer design
Based upon analysis of multiple influenza sequence alignments,
pan-influenza virus RT-PCR primer sets were developed that
were capable of amplifying all three influenza virus species (A, B,
and C) and subtypes (HxNy) from different animal hosts (e.g.,
human, avian, and swine) and distinguishing essential molecular
features using base composition signatures. Additional primer
pairs were designed that broadly amplified all known members of
a particular species, but that did not cross-amplify members of
different species (e.g., pan-influenza A and pan-influenza B
primers). A surveillance panel of eight primer pairs (Table S1)
was selected comprising one pan-influenza primer pair targeting
the PB1 segment, five pan-influenza A primer pairs targeting NP,
M1, PA, and the NS segments, and two pan-influenza B primer
pairs targeting NP and PB2 segments. All primers used in this
study had a thymine nucleotide at the 59 end to minimize addition
of non-templated adenosines during amplification using Taq
polymerase[24]. The sensitivity of each RT-PCR primer pair was
determined using known quantities of a synthetic calibrant RNA
template as described previously[20]. Each of the primer pairs was
sensitive to as few as twenty copies of the calibrant RNA and
several primers were sensitive to five copies (Table S1).
Reverse transcription PCR (RT-PCR)
One-step RT-PCR was performed in a reaction mix consisting of
4 U of AmpliTaq Gold (Applied Biosystems, Foster City, CA);
20 mM Tris, pH 8.3; 75 mM KCl; 1.5 mM MgCl2;0 . 4Mb e t a i n e ;
800 mM mix of dATP, dGTP, dCTP, and dTTP (Bioline USA Inc.,
Randolph, MA); 10 mM dithiothreitol; 100 ng sonicated polyA
DNA (Sigma Corp., St Louis, MO); 40 ng random hexamers
(Invitrogen Corp.); 1.2 U Superasin (Ambion Corp, Austin, TX);
400 ng T4 gene 32 protein (Roche Diagnostics Corp., Indianapolis,
IN); 2 U Superscript III (Invitrogen Corp, Carlsbad CA.); 20 mM
sorbitol (Sigma Corp.); and 250 nM of each primer. The following
RT-PCR cycling conditions were used: 60uCf o r5m i n ,4 uCf o r
10 min, 55uC for 45 min, 95uC for 10 min, followed by 8 cycles of
95uC for 30 seconds,48uC for 30 seconds, and 72uC for 30 seconds,
with the 48uC annealing temperature increasing 0.9uCe a c hc y c l e .
The PCR was then continued for 37 additional cycles of 95uCf o r
15 seconds, 56uC for 20 seconds, and 72uC for 20 seconds. The
RT-PCR cycle ended with a final extension of 2 min at 72uC
followed by a 4uC hold.
Mass spectrometry and base composition analysis
The RT-PCR products were analyzed using the Ibis T5000
universal biosensor platform (Ibis Biosciences, Inc., Carlsbad, CA;
http://www.ibisbiosciences.com), which performs automated
post-PCR desalting, ESI-MS signal acquisition, spectral analysis,
and data reporting as described previously[23]. Briefly, the steps
were as follows: 15 mL aliquots of each PCR reaction were
desalted and purified using a weak anion exchange protocol as
described elsewhere[25]. Accurate mass (61 ppm), high-resolution
(M/dM.100,000 FWHM) mass spectra were acquired for each
sample using high-throughput ESI-MS protocols described pre-
viously[20]. For each sample, approximately 1.5 mL of analyte
solution was consumed during the 74-second spectral acquisition.
Raw mass spectra were post-calibrated with an internal mass
standard and deconvolved to monoisotopic molecular masses.
Unambiguous base compositions were derived from the exact
mass measurements of the complementary single-stranded oligo-
nucleotides[26]. Quantitative results are obtained by comparing
the peak heights with an internal PCR calibration standard
present in every PCR well at 100 molecules[20].
Phylogenetic analysis
To demonstrate the capabilities of RT-PCR/ESI-MS to track the
evolution of circulating influenza viruses, we used a bioinformatic
approachtodevelop a frameworkonwhich to displaythe RT-PCR/
ESI-MS results obtained with H3N2 viruses. Complete genome
sequences of all H3N2 human influenza viruses available in
GenBank were analyzed. A total of 731 genomes were included,
from which we inferred the phylogeny of H3N2 influenza virus since
1996. Using the 565-nucleotideconcatenatedsequence ofthesix loci
that we analyzed by RT-PCR/ESI-MS, we constructed a non-
redundant alignment of 105 sequence types. Base compositions were
determined for each genome segment (i.e., locus) analyzed and each
unique base composition at each of these loci was assigned a letter
according to decreasing number of occurrences (therefore, the letter
A represents the most common allele identified at each locus). The
concatenation of the six base-composition letters from the PB1, NP,
M1,PA, NS1, andNS2 locifrom thesequencesof731H3N2viruses
(1996–2005) available in GenBank yielded 95 six-letter codes
referred to as base composition types (BC types). The predominant
type islabeled AAAAAA. The topology ofthe tree wasthen deduced
from the alignment of non-redundant sequences using the programs
dnadist and neighbor from the Phylip package (http://evolution.
genetics.washington.edu/phylip.html). Since the sequence types
differ mostly by discrete single mutations, the original computer-
generated tree was then extensively edited using graphics tools to
place the labels of intermediate types within the tree itself in lieu of
zero-length branches. Readability was further improved by sorting
parallel branches chronologically.
SUPPORTING INFORMATION
Table S1 Influenza virus primer pairs used in this study.
Genbank reference sequence for each segment is indicated;
however, the primer sequences are not identical to the reference
sequence as described in the Methods. The limits of detection for
each RT-PCR primer pair were determined using known
quantities of a synthetic calibrant RNA template.
Found at: doi:10.1371/journal.pone.0000489.s001 (0.06 MB PDF)
Table S2 Distribution of BC-types observed in influenza A
H3N2 positive human respiratory samples. Unique base composi-
tions at each genome segment locus analyzed were assigned letter
codes and concatenation of letter codes across the six loci analyzed
yielded BC-types. H1N1 samples were not assigned a BC-type.
Experimentally determined BC-types (marked RT-PCR/ESI-MS
Analysis results) were compared to BC-type signature information
of sequences currently available in GenBank and the closest
matching strain is shown (right pane). Last column shows
comparison to clade designation described in Holmes et al [12].
Found at: doi:10.1371/journal.pone.0000489.s002 (0.24 MB
PDF)
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PLoS ONE | www.plosone.org 8 May 2007 | Issue 5 | e489Table S3 Mutations observed in influenza virus isolates in 2005–
06 season. Out of the 174 influenza A H3N2 positive samples
analyzed from the 2005–2006 season, 29 genotypes were assigned
based on RT-PCR/ESI-MS and 30 were assigned based on
sequencing. There were no instances of ‘‘ESI-MS silent’’
compensating double mutations (e.g., simultaneous A.G and
G.A within the same amplicon leading to no change in the
observed BC-type) as verified by sequencing.
Found at: doi:10.1371/journal.pone.0000489.s003 (0.10 MB
PDF)
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